I briefly worked for a startup back in 2005 that was doing data analysis on prescriptions to reverse analyze a patient's conditions.
The customers were the insurance companies.
Re:A new book critiques medicine
by lonelappde on Sunday July 14, 2019 @07:09PM
(#20436867)
How does that work? Insurance companies have access to all the prescription purchase and tests ordered,but not the diagnoses?
I've read Bad Pharma (and will recommend it to anyone interested in this subject). And one way to summarize (perhaps oversimplify) it is: pharmaceutical corporations manipulate data to justify expensive drugs of questionable effectivness.
But to think "startups and tech companies" are going to help solve this problem... man, that's optimistic. And as Bad Pharma demonstrates, the data is already available. There's just not a lot of interest (economically or politically, especially where those two are strongly correlated) to seek it out or listen to it.
Also I don't think it was HIPAA's intention to hide data from well-meaning startups. That's just an unintended consequence perhaps. I'd like to think its primary motivation was to protect patient data from predatory insurance companies and unscrupulous marketing forces. (Does it succeed in doing that? I don't know. Are startups and tech companies going to help with that if it doesn't? Hmmm.)